1 | 100 mg ELX (VX-445) / 50 mg TEZ / 75 mg IVA FDC | - | - | - | - | 1件: 299 299 |
2 | 100 mg ELX /50 mg TEZ /75 mg IVA FDC | - | - | - | - | 1件: 299 299 |
3 | 100 mg ELX/50 mg TEZ /75 mg IVA FDC | - | - | - | - | 1件: 299 299 |
4 | 100 mg ELX/50 mg TEZ/75 mg IVA fixed dose combination | - | - | - | - | 1件: 299 299 |
5 | 100 mg VX-445 /50 mg TEZ/75 mg IVA FDC | - | - | - | - | 1件: 299 299 |
6 | 100 mg VX-445/50 mg TEZ /75 mg IVA FDC | - | - | - | - | 1件: 299 299 |
7 | 100-mg ELX (VX-445) / 50-mg TEZ / 75-mg IVA FDC | - | - | - | - | 1件: 299 299 |
8 | 100-mg ELX (VX-455) / 50-mg TEZ / 75-mg IVA FDC | - | - | - | - | 1件: 299 299 |
9 | 100-mg ELX / 50-mg TEZ / 75 -mg | - | - | - | - | 1件: 299 299 |
10 | 100-mg ELX / 50-mg TEZ / 75 -mg IVA FDC | - | - | - | - | 1件: 299 299 |
11 | 100-mg VX-445 / 50-mg TEZ / 75- mg IVA FDC | - | - | - | - | 1件: 299 299 |
12 | 100-mg VX-445 / 50-mg TEZ / 75-mg IVA FDC | - | - | - | - | 1件: 299 299 |
13 | 100-mg VX-445 /50-mg TEZ/75-mg | - | - | - | - | 1件: 299 299 |
14 | 100-mg VX-445/50-mg TEZ/75-mg IVA FDC | - | - | - | - | 1件: 299 299 |
15 | 100g ELX / 50mg TEZ / 75mg IVA | - | - | - | - | 1件: 299 299 |
16 | 100mg ELX/50mg TEZ /75mg IVA | - | - | - | - | 1件: 299 299 |
17 | 100mg VX-445/50mg TEZ /75mg IVA FDC | - | - | - | - | 1件: 299 299 |
18 | 56/104/75-C | - | - | - | - | 1件: 50 50 |
19 | 75 | - | - | - | - | 1件: 6 6 |
20 | 75 mg Ontamalimab | 1件: Ontamalimab Ontamalimab | - | - | - | 2件: 96 96, 97 |
21 | 75-mg IVACAFTOR | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
22 | 750 mg metformin and 7.5 g L-citrulline daily p.o. | 2件: Citrulline Citrulline, Metformin (Synonym: Metformin ER 750 mg) | 3件: D00944
D00944
,
D04966
,
D07706
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 113 113 |
23 | 750mg mesalazine pellets | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
24 | 755nm Alexandrite Laser | - | - | - | - | 1件: 34 34 |
25 | 75mg CXA-10 | 1件: CXA-10 CXA-10 | - | - | - | 1件: 86 86 |
26 | 75mg SHP647 (PF-00547659) | - | - | - | - | 1件: 97 97 |
27 | AIN457, 75 mg | - | - | - | - | 1件: 271 271 |
28 | Atacicept 75 mg | 1件: Atacicept Atacicept | 1件: D09704
D09704
| 2件: TNFSF13 TNFSF13, TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 3件: 13 13, 49, 66 |
29 | Atacicept 75 milligram (mg) | 1件: Atacicept Atacicept | 1件: D09704
D09704
| 2件: TNFSF13 TNFSF13, TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件: 49 49 |
30 | AZLI 75 mg three times a day (TID) | - | - | - | - | 1件: 299 299 |
31 | AZLI 75 mg three times daily (TID) | - | - | - | - | 1件: 299 299 |
32 | AZLI 75 mg two times a day (BID)/ three times a day (TID) | - | - | - | - | 1件: 299 299 |
33 | AZLI 75 mg two times a day (BID)/three times a day (TID) | - | - | - | - | 1件: 299 299 |
34 | Betaloc ZOK 25, 23,75 mg | - | - | - | - | 1件: 113 113 |
35 | BMS-986004 75 mg IV | - | - | - | - | 1件: 63 63 |
36 | Bupivacaine (Synonym: DURAPREN 0.75%) | 1件: Bupivacaine Bupivacaine | 2件: D01450
D01450
(Name: DURAPREN 0.75%),
D07552
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 8件: 46 46, 51, 53, 70, 96, 168, 226, 298 |
37 | BUPIVACAINE HYDROCHLORIDE (Synonym: DURAPREN 0.75%) | 1件: Bupivacaine Bupivacaine | 2件: D01450
D01450
(Name: DURAPREN 0.75%),
D07552
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 2件: 46 46, 53 |
38 | Bupivacaine hydrochloride 0.5% (Marcaine, Pfizer) (Synonym: DURAPREN 0.75%) | 1件: Bupivacaine Bupivacaine | 2件: D01450
D01450
(Name: DURAPREN 0.75%),
D07552
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 46 46 |
39 | Bupivacaine Injection 0.5% (Synonym: DURAPREN 0.75%) | 1件: Bupivacaine Bupivacaine | 2件: D01450
D01450
(Name: DURAPREN 0.75%),
D07552
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 168 168 |
40 | Bupivacaine, triamcinolone, and heparin (BTH) (Synonym: DURAPREN 0.75%) | 3件: Bupivacaine Bupivacaine, Heparin, Triamcinolone | 8件: D00385
D00385
,
D00983
,
D00984
,
D00985
,
D01450
(Name: DURAPREN 0.75%),
D06216
,
D07510
,
D07552
| 7件: NR3C1 NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 | 5件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction 💬 | 1件: 226 226 |
41 | Bupivacaine-Epinephrine 0.25%-1:200,000 Injectable Solution plus clonidine (Synonym: DURAPREN 0.75%) | 3件: Bupivacaine Bupivacaine, Clonidine, Epinephrine | 7件: D00095
D00095
,
D00281
,
D00604
,
D00996
,
D01450
(Name: DURAPREN 0.75%),
D02149
,
D07552
| 14件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 70 70 |
42 | Bupivacaine/epinephrine/dexamethasone (Synonym: DURAPREN 0.75%) | 3件: Bupivacaine Bupivacaine, Dexamethasone, Epinephrine | 14件: D00095
D00095
,
D00292
,
D00975
,
D00996
,
D01450
(Name: DURAPREN 0.75%),
D01510
,
D01615
,
D01632
,
D01948
,
D02149
,
D02174
,
D02591
,
D02592
,
D07552
| 15件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 96 96 |
43 | Catapresan 75 | - | - | - | - | 1件: 78 78 |
44 | Catapresan 75, Tabletten | - | - | - | - | 1件: 65 65 |
45 | Cayston 75 mg Pulver und Lösungsmittel zur Herstellung einer Lösung für einen Vernebler | 1件: Aztreonam Aztreonam | 2件: D00240
D00240
,
D06558
| - | - | 1件: 299 299 |
46 | CAYSTON aztreonam 75 mg powder and solvent for nebuliser solution | 1件: Aztreonam Aztreonam | 2件: D00240
D00240
,
D06558
| - | - | 1件: 299 299 |
47 | Certican 0,75mg | 1件: Everolimus Everolimus | 1件: D02714
D02714
| 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 1件: 228 228 |
48 | Certican 0,75mg Tabletten | 1件: Everolimus Everolimus | 1件: D02714
D02714
| 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 1件: 228 228 |
49 | Cohort 2 0.75g | - | - | - | - | 1件: 240 240 |
50 | Colistimethate 75 mg inhaled two times daily | 1件: Colistimethate Colistimethate | 1件: D02049
D02049
| - | - | 1件: 299 299 |
51 | Comparator: diclofenac (Synonym: DFS 75MG DR/MS 25%/MENTH 6%/CAP 0.025% PAK) | 1件: Diclofenac Diclofenac (Synonym: NuDroxiPAK DSDR-75) | 3件: D00903
D00903
,
D00904
(Name: DFS 75MG DR/MS 25%/MENTH 6%/CAP 0.025% PAK),
D07816
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 |
52 | Comparator: Diclofenac sodium (Synonym: DFS 75MG DR/MS 25%/MENTH 6%/CAP 0.025% PAK) | 1件: Diclofenac Diclofenac (Synonym: NuDroxiPAK DSDR-75) | 3件: D00903
D00903
,
D00904
(Name: DFS 75MG DR/MS 25%/MENTH 6%/CAP 0.025% PAK),
D07816
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 |
53 | CVL-751 | - | - | - | - | 1件: 6 6 |
54 | Depot leuprolide acetate 3.75 mg | 2件: Acetate Acetate, Leuprolide | 1件: D00989
D00989
| 1件: GNRHR GNRHR 💬 | 2件: GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 51 51 |
55 | Diclofenac (Synonym: DFS 75MG DR/MS 25%/MENTH 6%/CAP 0.025% PAK) | 1件: Diclofenac Diclofenac (Synonym: NuDroxiPAK DSDR-75) | 3件: D00903
D00903
,
D00904
(Name: DFS 75MG DR/MS 25%/MENTH 6%/CAP 0.025% PAK),
D07816
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 5件: 13 13, 34, 46, 78, 271 |
56 | Diclofenac + Omeprazole (Synonym: DFS 75MG DR/MS 25%/MENTH 6%/CAP 0.025% PAK) | 2件: Diclofenac Diclofenac (Synonym: NuDroxiPAK DSDR-75), Omeprazole | 7件: D00455
D00455
,
D00903
,
D00904
(Name: DFS 75MG DR/MS 25%/MENTH 6%/CAP 0.025% PAK),
D01207
,
D05259
,
D05261
,
D07816
| 4件: ATP4A ATP4A, ATP4B, PTGS1, PTGS2 💬 | 26件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 |
57 | Diclofenac 50 milligrams (Synonym: DFS 75MG DR/MS 25%/MENTH 6%/CAP 0.025% PAK) | 1件: Diclofenac Diclofenac (Synonym: NuDroxiPAK DSDR-75) | 3件: D00903
D00903
,
D00904
(Name: DFS 75MG DR/MS 25%/MENTH 6%/CAP 0.025% PAK),
D07816
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 271 271 |
58 | Diclofenac Sodium (Synonym: DFS 75MG DR/MS 25%/MENTH 6%/CAP 0.025% PAK) | 1件: Diclofenac Diclofenac (Synonym: NuDroxiPAK DSDR-75) | 3件: D00903
D00903
,
D00904
(Name: DFS 75MG DR/MS 25%/MENTH 6%/CAP 0.025% PAK),
D07816
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 2件: 34 34, 46 |
59 | Diclofenac sodium topical gel (Synonym: DFS 75MG DR/MS 25%/MENTH 6%/CAP 0.025% PAK) | 1件: Diclofenac Diclofenac (Synonym: NuDroxiPAK DSDR-75) | 3件: D00903
D00903
,
D00904
(Name: DFS 75MG DR/MS 25%/MENTH 6%/CAP 0.025% PAK),
D07816
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 13 13 |
60 | Diclofenac SR (Synonym: DFS 75MG DR/MS 25%/MENTH 6%/CAP 0.025% PAK) | 1件: Diclofenac Diclofenac (Synonym: NuDroxiPAK DSDR-75) | 3件: D00903
D00903
,
D00904
(Name: DFS 75MG DR/MS 25%/MENTH 6%/CAP 0.025% PAK),
D07816
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 271 271 |
61 | Dulaglutide 0.75Mg/0.5Ml Inj Pen | 1件: Dulaglutide Dulaglutide | 1件: D09889
D09889
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 299 299 |
62 | Ebetrex 15 mg = 0,75 ml, oplossing voor injectie in voorgevulde injectiespuit 20 mg/ml | - | - | - | - | 1件: 96 96 |
63 | Efexor XL 75 mg | - | - | - | - | 1件: 46 46 |
64 | Efexor XL 75 mg (venlafaxine) | 1件: Venlafaxine Venlafaxine | 2件: D00821
D00821
,
D08670
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 46 46 |
65 | ERCP with Bupivacaine infusion (Synonym: DURAPREN 0.75%) | 1件: Bupivacaine Bupivacaine | 2件: D01450
D01450
(Name: DURAPREN 0.75%),
D07552
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 298 298 |
66 | IncobotulinumtoxinA (75 Units) | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 6 6 |
67 | Inhaled nitric oxide 75 mcg/kg IBW/hr | 1件: Nitric Oxide Nitric Oxide | 1件: D00074
D00074
| - | - | 2件: 85 85, 86 |
68 | INM-755 | - | - | - | - | 1件: 36 36 |
69 | INM-755 (cannabinol) cream | 1件: Cannabinol Cannabinol | - | - | - | 1件: 36 36 |
70 | Intravenous Infusion of Diclofenac Sodium (Synonym: DFS 75MG DR/MS 25%/MENTH 6%/CAP 0.025% PAK) | 1件: Diclofenac Diclofenac (Synonym: NuDroxiPAK DSDR-75) | 3件: D00903
D00903
,
D00904
(Name: DFS 75MG DR/MS 25%/MENTH 6%/CAP 0.025% PAK),
D07816
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 78 78 |
71 | Irbesartan tablets (NDA 020 757) | 1件: Irbesartan Irbesartan | 1件: D00523
D00523
| 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 66 66 |
72 | Ivacaftor 25 mg/75 mg | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
73 | Ivacaftor 75 mg | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
74 | Ivacaftor 75 mg/150 mg | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
75 | IVACAFTOR 75mg | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
76 | Jaktinib Dihydrochloride Monohydrate 50mg BID and Mimic tablets of jakitinib hydrochloride 75mg BID and Acetylcysteine Effervescent Tablets | 1件: Acetylcysteine Acetylcysteine | 1件: D00221
D00221
| - | - | 1件: 85 85 |
77 | Jaktinib Dihydrochloride Monohydrate 75mg BID and Mimic tablets of jakitinib hydrochloride 50mg BID and Acetylcysteine Effervescent Tablets | 1件: Acetylcysteine Acetylcysteine | 1件: D00221
D00221
| - | - | 1件: 85 85 |
78 | JNJ-54781532 75 mg once daily | - | - | - | - | 1件: 97 97 |
79 | JNJ-54781532 75 mg twice daily | - | - | - | - | 1件: 97 97 |
80 | Lap TAP Bupivacaine/Epinephrine (Synonym: DURAPREN 0.75%) | 2件: Bupivacaine Bupivacaine, Epinephrine | 5件: D00095
D00095
,
D00996
,
D01450
(Name: DURAPREN 0.75%),
D02149
,
D07552
| 14件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 96 96 |
81 | Leuprorelin Acetate 3.75mg Injection | 2件: Acetate Acetate, Leuprolide | 1件: D00989
D00989
| 1件: GNRHR GNRHR 💬 | 2件: GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 76 76 |
82 | Levodopa 75 mg A CAP | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
83 | Liposomal bupivacaine (Synonym: DURAPREN 0.75%) | 1件: Bupivacaine Bupivacaine | 2件: D01450
D01450
(Name: DURAPREN 0.75%),
D07552
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 3件: 51 51, 70, 96 |
84 | LIQ861 75 µg | - | - | - | - | 1件: 86 86 |
85 | Luphere depot 3.75mg(Leuprolide acetate 3.75mg) | 2件: Acetate Acetate, Leuprolide | 1件: D00989
D00989
| 1件: GNRHR GNRHR 💬 | 2件: GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 76 76 |
86 | M2951 75 mg QD | - | - | - | - | 1件: 46 46 |
87 | Macitentan 75 mg | 1件: Macitentan Macitentan | 1件: D10135
D10135
| 2件: EDNRA EDNRA, EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
88 | MetoHEXAL® Succ ® 23,75 mg Retardtabletten | - | - | - | - | 1件: 113 113 |
89 | Oral Glucose Tolerance test (75g 2-hour) | 1件: Dextrose, unspecified form Dextrose, unspecified form (Synonym: 75gm Glucose Tolerance Drink) | - | - | - | 1件: 299 299 |
90 | Other: glucose solution at a dose of 1.75 g/kg (up to a maximum of 75 g) for the OGTT and glucose solution at a dose of 0.5 g/kg (up to a maximum of 35 g) was injected in 2.5-3 min for the IGTT | 1件: Dextrose, unspecified form Dextrose, unspecified form (Synonym: 75gm Glucose Tolerance Drink) | - | - | - | 1件: 299 299 |
91 | Over-encapsulated 75 mg Irbesartan Tablets | 1件: Irbesartan Irbesartan | 1件: D00523
D00523
| 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 222 222 |
92 | P2B001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg), | 2件: Pramipexole Pramipexole, Rasagiline | 5件: D00559
D00559
,
D02562
,
D05575
,
D08469
,
D10829
| 4件: DRD2 DRD2, DRD3, DRD4, MAOB 💬 | 18件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
93 | P2B001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg), | 2件: Pramipexole Pramipexole, Rasagiline | 5件: D00559
D00559
,
D02562
,
D05575
,
D08469
,
D10829
| 4件: DRD2 DRD2, DRD3, DRD4, MAOB 💬 | 18件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
94 | P38 Inhibitor (4) 75mg | - | - | - | - | 1件: 46 46 |
95 | Pregabalin 75mg | 1件: Pregabalin Pregabalin (Synonym: Pregabalin-75) | 1件: D02716
D02716
| 4件: CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 | 7件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬 | 1件: 70 70 |
96 | RANEXA - 750 MG - COMPRESSA A RILASCIO PROLUNGATO- USO ORALE - BLISTER (PVC/PVDC/ALLUMINIO) 60 COMPRESSE | 1件: Ranolazine Ranolazine | 2件: D05700
D05700
,
D05701
| - | - | 1件: 58 58 |
97 | RANEXA*60CPR 750MG R.P. | 1件: Ranolazine Ranolazine | 2件: D05700
D05700
,
D05701
| - | - | 1件: 58 58 |
98 | Ranolazine 750 mg PR tablets | 1件: Ranolazine Ranolazine | 2件: D05700
D05700
,
D05701
| - | - | 1件: 58 58 |
99 | Ranolazine PR (prolonged-release) 500 mg 1 tablet bis in die and 750 mg 1 tablet bis in die | 1件: Ranolazine Ranolazine | 2件: D05700
D05700
,
D05701
| - | - | 1件: 58 58 |
100 | Revolade 75 mg | 1件: Eltrombopag Eltrombopag | - | - | - | 1件: 60 60 |
101 | RhuDex 25 mg (31.75 mg RhuDex choline salt) granules | 1件: Choline Choline (Synonym: Mega-vim 75 With Beta-carotene - Tablets) | 1件: D07690
D07690
| - | - | 1件: 93 93 |
102 | RO 487-7533 | - | - | - | - | 1件: 46 46 |
103 | Ro 487-7533/F01 | - | - | - | - | 3件: 46 46, 107, 271 |
104 | Ro 487-7533/F10 | - | - | - | - | 2件: 46 46, 107 |
105 | Ro 487-7533/F10-02 | - | - | - | - | 1件: 46 46 |
106 | Ro 487-7533/F10-04 | - | - | - | - | 4件: 41 41, 46, 51, 107 |
107 | Ro 491-7523/F18 | - | - | - | - | 1件: 206 206 |
108 | Ro 491-7523/F19 | - | - | - | - | 1件: 206 206 |
109 | Ro487-7533 | - | - | - | - | 1件: 46 46 |
110 | RO487-7533/F01-F05 | - | - | - | - | 1件: 46 46 |
111 | RO487-7533/F10-04 | - | - | - | - | 2件: 46 46, 51 |
112 | Secukinumab (75 mg) | 1件: Secukinumab Secukinumab | 1件: D09967
D09967
| 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 271 271 |
113 | Secukinumab 75 mg/0.5 ml Solution for injection | 1件: Secukinumab Secukinumab | 1件: D09967
D09967
| 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 271 271 |
114 | SUSPENSION CONTAINING 7500 EMBRYONATED VIABLE TRICHURIS SUIS OVA/15ML | - | - | - | - | 1件: 97 97 |
115 | Suspension containing 7500 embryonated, viable Trichuris suis ova (TSO)/15ml | - | - | - | - | 1件: 96 96 |
116 | Suspension of 7500 embryonated, viable TSO/15ml | - | - | - | - | 1件: 96 96 |
117 | TAK-755 | - | - | - | - | 1件: 64 64 |
118 | TAK-755 or BAX930 or SHP655 | - | - | - | - | 1件: 64 64 |
119 | TAK-755 orBAX930 or SHP655 | - | - | - | - | 1件: 64 64 |
120 | Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere | 1件: Dulaglutide Dulaglutide | 1件: D09889
D09889
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 13 13 |
121 | Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere. | 1件: Dulaglutide Dulaglutide | 1件: D09889
D09889
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 13 13 |
122 | TSO 7500 | - | - | - | - | 1件: 96 96 |
123 | US TAP Bupivacaine/Epinephrine (Synonym: DURAPREN 0.75%) | 2件: Bupivacaine Bupivacaine, Epinephrine | 5件: D00095
D00095
,
D00996
,
D01450
(Name: DURAPREN 0.75%),
D02149
,
D07552
| 14件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 96 96 |
124 | Vamorolone 0.75 mg/day/day | 1件: Vamorolone Vamorolone | 1件: D11000
D11000
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 |
125 | Vamorolone 0.75 mg/kg/day | 1件: Vamorolone Vamorolone | 1件: D11000
D11000
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 |
126 | Veltuzumab solution 75mg/ml | 1件: Veltuzumab Veltuzumab | 1件: D09031
D09031
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
127 | VX-661/ivacaftor 50 mg/ 75 mg | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
128 | XYOSTED 75 milligram (mg) in 0.5 ML Auto-Injector | 1件: Testosterone enanthate Testosterone enanthate | 1件: D00958
D00958
| 1件: AR AR 💬 | 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 1件: 13 13 |